Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application
- PMID: 27865609
- DOI: 10.1016/j.xphs.2016.10.001
Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application
Abstract
In the recent decade, skin delivery (topical and transdermal) has gained an unprecedented popularity, especially due to increased incidences of chronic skin diseases, demand for targeted and patient compliant delivery, and interest in life cycle management strategies among pharmaceutical companies. Literature review of recent publications indicates that among various skin delivery systems, lipid-based delivery systems (vesicular carriers and lipid particulate systems) have been the most successful. Vesicular carriers consist of liposomes, ultradeformable liposomes, and ethosomes, while lipid particulate systems consist of lipospheres, solid lipid nanoparticles, and nanostructured lipid carriers. These systems can increase the skin drug transport by improving drug solubilization in the formulation, drug partitioning into the skin, and fluidizing skin lipids. Considering that lipid-based delivery systems are regarded as safe and efficient, they are proving to be an attractive delivery strategy for the pharmaceutical as well as cosmeceutical drug substances. However, development of these delivery systems requires comprehensive understanding of physicochemical characteristics of drug and delivery carriers, formulation and process variables, mechanism of skin delivery, recent technological advancements, specific limitations, and regulatory considerations. Therefore, this review article encompasses recent research advances addressing the aforementioned issues.
Keywords: colloid; controlled release; drug delivery systems; lipids; liposomes; nanoparticles; percutaneous; permeability; skin; transdermal drug delivery.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Recent advances and development in epidermal and dermal drug deposition enhancement technology.Int J Dermatol. 2018 Jun;57(6):646-660. doi: 10.1111/ijd.13902. Epub 2018 Feb 12. Int J Dermatol. 2018. PMID: 29430629 Review.
-
Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.Eur J Pharm Biopharm. 2018 Jun;127:387-397. doi: 10.1016/j.ejpb.2018.03.008. Epub 2018 Mar 23. Eur J Pharm Biopharm. 2018. PMID: 29581043
-
Vesicular carriers for dermal drug delivery.Expert Opin Drug Deliv. 2009 Aug;6(8):813-25. doi: 10.1517/17425240903071029. Expert Opin Drug Deliv. 2009. PMID: 19569979 Review.
-
Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery.AAPS PharmSciTech. 2024 Aug 13;25(6):184. doi: 10.1208/s12249-024-02896-6. AAPS PharmSciTech. 2024. PMID: 39138693 Review.
-
Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.Int J Pharm. 2018 Jan 15;535(1-2):1-17. doi: 10.1016/j.ijpharm.2017.10.046. Epub 2017 Oct 27. Int J Pharm. 2018. PMID: 29111097 Review.
Cited by
-
A Comprehensive Review on Niosomes as a Strategy in Targeted Drug Delivery: Pharmaceutical, and Herbal Cosmetic Applications.Curr Drug Deliv. 2024;21(11):1460-1473. doi: 10.2174/0115672018269199231121055548. Curr Drug Deliv. 2024. PMID: 38231066 Review.
-
Follicular mediated etodolac phosalosomal gel for contact dermatitis alleviation, insights from optimization to in-vivo appraisal.Sci Rep. 2024 Sep 18;14(1):21744. doi: 10.1038/s41598-024-71456-6. Sci Rep. 2024. PMID: 39289408 Free PMC article.
-
Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments.Int J Nanomedicine. 2018 Oct 9;13:6109-6121. doi: 10.2147/IJN.S178077. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30349240 Free PMC article. Review.
-
Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations.Medicines (Basel). 2018 Dec 29;6(1):7. doi: 10.3390/medicines6010007. Medicines (Basel). 2018. PMID: 30597953 Free PMC article. Review.
-
Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development.Pharmaceutics. 2022 Apr 11;14(4):831. doi: 10.3390/pharmaceutics14040831. Pharmaceutics. 2022. PMID: 35456665 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical